Current options for predicting the effectiveness of systemic therapy for metastatic renal cell carcinoma

Abstract

The goal of this communication is to describe the use of the currently available molecular markers and selected clinical biomarkers in predicting the effectiveness of systemic therapy for the treatment of metastatic renal cell carcinoma (mRCC).

Keywords

• molecular marker
• renal cell carcinoma
• metastatic
• targeted therapy